Science & Research
Wastewater Monitoring Could Offer Early Warning for Influenza Outbreaks, Japanese Study Suggests
A new study indicates that wastewater surveillance can predict influenza outbreaks up to a week earlier than patient data, aiding resource planning and public health responses, especially in underserved areas.
Powermax Minerals Identifies Priority Drill Targets at Atikokan Rare Earth Property Amid Growing Demand for Domestic Supply
Powermax Minerals has defined two priority geological environments at its Atikokan Rare Earth Property in Ontario, advancing toward drilling as the market seeks secure rare earth sources.
SureNano Science's GEP-44 Could Disrupt the Obesity Drug Market with Improved Tolerability
SureNano Science Ltd. is advancing GEP-44, a next-generation GLP-1 therapy with a triple agonist mechanism, aiming to improve upon current obesity treatments by offering better tolerability and potential non-injectable delivery.
NanoViricides Raises $2 Million in Registered Direct Offering to Advance Broad-Spectrum Antiviral Drug
NanoViricides announced a $2 million registered direct offering with a single institutional investor, aiming to fund development of its broad-spectrum antiviral NV-387, which targets multiple viruses including COVID-19, influenza, and RSV.
Oncotelic Therapeutics Highlights CNS Drug Delivery Innovation in NetworkNewsAudio Editorial
Oncotelic Therapeutics was featured in a NetworkNewsAudio editorial discussing the challenges of the blood-brain barrier and the company's N2B delivery system, with implications for biodefense and Alzheimer's treatment.
Annovis Bio Achieves 85% Enrollment in Phase 3 Alzheimer’s Trial, Advances Parkinson’s Program
Annovis Bio reports first-quarter progress with 85% enrollment in its pivotal Phase 3 Alzheimer's trial and 40% enrollment in its Parkinson's open-label study, signaling potential regulatory milestones for buntanetap.
NanoViricides Advances Broad-Spectrum Antiviral NV-387 Toward Phase II Trials for MPox in DRC
NanoViricides' quarterly report details progress with NV-387, including regulatory approval for Phase II MPox trials in the DRC and FDA orphan drug designation for measles, highlighting its broad-spectrum antiviral strategy.
Pensacola Dentist Merges Hyperbaric and Metabolic Therapy with Dental Care to Treat Systemic Health
Biodental Health and Longevity has expanded its services to include hyperbaric oxygen therapy and PNOE metabolic breath analysis, integrating systemic wellness with dental care to address the connection between oral health and chronic disease.
GeoVax Advances GEO-MVA Phase 3 Trial as Mpox Vaccine Supply Concerns Persist
GeoVax reports first quarter 2026 financial results and details plans for a pivotal Phase 3 immunobridging study of its MVA-based mpox/smallpox vaccine, highlighting the strategic importance of diversifying orthopoxvirus vaccine supply amid global supply constraints.
Kairos Pharma Receives 2026 Healthcare Innovation Award for Drug Resistance Research
Kairos Pharma has been recognized with the 2026 GHP Magazine Healthcare & Pharmaceutical Award as the USA leader in drug resistance development, highlighting its work on cancer therapeutics that address treatment resistance.
SureNano Science Featured in BioMedWire Editorial Highlighting GLP-1 Innovation
SureNano Science Ltd. was featured in a BioMedWire editorial discussing its subsidiary GlucaPharm Inc. and its GEP-44 triple agonist peptide, which aims to improve obesity and diabetes treatment with better tolerability and potential non-injectable delivery.
Tonix Pharmaceuticals to Present Real-World Data on Fibromyalgia Treatment at ISPOR 2026
Tonix Pharmaceuticals will present findings from a retrospective cohort study on fibromyalgia treatment patterns using U.S. claims data, offering insights into real-world usage following the launch of its newly approved drug TONMYA.
Oncotelic Therapeutics Featured in Editorial Highlighting Intranasal Drug Delivery for Alzheimer's and Biodefense
Oncotelic Therapeutics' intranasal nose-to-brain delivery platform, featured in a BioMedWire editorial, addresses key challenges in CNS drug delivery for Alzheimer's disease and biodefense research by bypassing the blood-brain barrier.
Testosterone Levels Linked to Glioblastoma Survival in Men, NIH-Funded Study Finds
A new NIH-funded preclinical study reveals that men with higher testosterone levels may have longer survival when diagnosed with glioblastoma, opening potential implications for treatments and companies like CNS Pharmaceuticals.
SureNano Science Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation
SureNano Science Ltd. and its subsidiary GlucaPharm Inc. are highlighted for developing GEP-44, a novel triple agonist peptide targeting the expanding GLP-1 market for obesity and metabolic disorders.
Tevard Biosciences Reports Full Dystrophin Restoration and Titin Rescue with Suppressor tRNA Therapy at ASGCT 2026
Tevard Biosciences presented preclinical data showing its suppressor tRNA therapy achieved complete dystrophin restoration in Duchenne muscular dystrophy models and robust titin rescue in cardiomyopathy models, highlighting the platform's potential for treating nonsense mutation diseases.
Innovotech Secures $234,000 in NRC IRAP Funding for Advanced Antimicrobial Testing Services
Innovotech Inc. receives up to $234,000 CAD from NRC IRAP to develop antimicrobial testing services for medical devices, addressing evolving regulatory standards and rising client demand.
Dr. Bahman Guyuron Honored with AAPS Honorary Award for Pioneering Contributions to Plastic Surgery
Dr. Bahman Guyuron, a leading plastic surgeon, has received the American Association of Plastic Surgeons' Honorary Award and Clinician of the Year recognition, underscoring his decades of innovation in facial surgery and migraine treatment.
Canine Bed Bug Detection Teams Complete Over 1,200 Inspections Across Tri-State Area in 2025
Tristate Bedbug Dogs reports that certified K9 teams conducted more than 1,200 inspections in NY/NJ/CT in 2025, highlighting the superior accuracy of canine detection over traditional visual methods.
Spanish Forensic Academy Expands Online Curriculum to 15+ Disciplines After 12 Years
Academia Internacional de Ciencias Criminalísticas has grown from a niche online criminalistics training provider to a comprehensive institution covering over 15 forensic disciplines, including cybercriminology, addressing professional education gaps for practitioners worldwide.
GeoVax Highlights Gedeptin's Role in Overcoming Immune Resistance in Cold Tumors
GeoVax Labs emphasizes its Gedeptin platform's potential to enhance checkpoint inhibitor efficacy by modulating the tumor microenvironment, positioning it as a key combination immunotherapy for immunologically cold tumors.
Andina Copper Reports Major Copper-Molybdenum Intercept at Cobrasco Project, Expanding Known Mineralization
Andina Copper's drillhole CDH008 at the Cobrasco Project in Colombia returned 272 meters of 0.50% copper, confirming northwest extension of the porphyry system, which remains open in all directions.
Perimenopause Identified as Critical Window for Heart Disease Prevention in Women
A new study reveals that perimenopausal women are twice as likely to have low cardiovascular health scores, highlighting this transition as a key opportunity for early intervention and lifestyle changes to prevent heart disease.
Wearable Devices Launches Mudra Pro Neural Sensing Platform for AI and XR Applications
Wearable Devices Ltd. announced the Mudra Pro, a wrist-worn neural sensing platform for developers and researchers in AI, XR, and human-machine interaction, highlighting its potential to advance touchless control and physiological computing.
Oncotelic Therapeutics Doses First Patient in Phase 1b Trial of Sapu003 for Advanced Solid Tumors
Oncotelic Therapeutics and Sapu Nano announced the first patient dosed in a Phase 1b trial of Sapu003, an IV formulation of everolimus, aiming to improve delivery and reduce toxicity for advanced mTOR-sensitive solid tumors.
Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
The rising prevalence of obesity and type 2 diabetes is driving significant interest in next-generation GLP-1 therapies, with companies like SureNano Science Ltd. developing novel triple agonists that could improve efficacy and tolerability in a rapidly expanding market.
SureNano Science Aims to Overcome GLP-1 Therapy Limitations with Triple Agonist Peptide
SureNano Science Ltd. is developing GEP-44, a triple agonist peptide targeting GLP-1 and PYY receptors, to address efficacy, tolerability, and delivery challenges in the rapidly expanding obesity and metabolic disease market.
Kairos Pharma CEO to Present at LD Micro Invitational, Highlighting Clinical Progress
Kairos Pharma CEO Dr. John Yu will present at the LD Micro Invitational, providing updates on the company's clinical trials for ENV-105, a promising oncology candidate targeting drug resistance in cancer.
Canamera Energy Metals Begins Drilling at São Sepé Rare Earth Project in Brazil
Canamera Energy Metals has started a 500-meter auger drill program at its São Sepé rare earth project in Brazil, targeting ionic adsorption clay-hosted mineralization across three priority zones.
Oncotelic’s Intranasal Brain Delivery Platform Highlighted as CNS Drug Development Gains Urgency
Oncotelic Therapeutics featured in BioMedWire editorial for its nose-to-brain delivery platform that bypasses the blood-brain barrier, with rising Alzheimer’s cases and biodefense needs driving demand for such technologies.